ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 2

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Review Article

1. Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics

Gul-e-Saba Chaudhry* , Abdah Akim, Muhammad Naveed Zafar, Naila Safdar, Yeong Yik Sung, Tengku Sifzizul Tengku Muhammad

Adv Pharm Bull. 2021;11(3): 426-438. doi: 10.34172/apb.2021.050

PMCID: PMC8421618 PMID: 34513617 Scopus ID: 85108917744

Article

PDF

Full Text

XML

Cited By:

Research Article

2. MiR-146a Restoration Suppresses Triple-Negative Breast Cancer Cell Migration: A Bioinformatic and In Vitro Study

Leila Tebbi , Behzad Mansoori, Sahar Safaei, Shahriar Hashemzadeh, Masoud Shirmohamadi, Khalil Hajiasgharzadeh, Mahdi Abdoli Shadbad, Behzad Baradaran*

Adv Pharm Bull. 2022;12(4): 842-849. doi: 10.34172/apb.2022.083

PMCID: PMC9675915 PMID: 36415628 Scopus ID: 85140272177

Article

PDF

Full Text

XML

Cited By:

Editorial

3. Exploring a Synergistic Approach: Dual GLP-1 Agonist Combined with Degludec Basal Insulin for Early Type 1 Diabetes Treatment and its Impact on Albumin-Insulin Producing Cells Expression

Amr Ahmed , Maher Monir. Akl*

Adv Pharm Bull. 2024;14(2): 262-265. doi: 10.34172/apb.2024.040

PMCID: PMC11347740 PMID: 39206389

Article

PDF

Full Text

XML

Cited By:

Original Article

4. Silencing Calumenin Expression via Artificial MicroRNA, a Potential Breakthrough for Inhibiting Proliferation, Halting Migration, and Triggering Apoptosis in Breast Cancer Cells

Zahra Amiri , Fatemeh Bahrami, Babak Jahangiri , Arash Javeri, Frouzandeh Mahjoubi, Nahid Nafissi, Mohammad Zaefizadeh, Fatemeh Masoumi, Alireza Zomorodipour*

Adv Pharm Bull. 2025;15(2): 453-466. doi: 10.34172/apb.025.43819

Article

PDF

XML

Cited By: